Dasatinib induced pleuro–pericardial effusion: To the Editor

Ajay Kumar  Mishra; Kamal Kant Sahu; Sudesh Kaul; Amos Lal

doi:10.23750/abm.v91i1.8914

Dasatinib induced pleuro–pericardial effusion

To the Editor

Authors

Ajay Kumar Mishra Department of Internal Medicine Saint Vincent Hospital Worcester, Massachusetts USA, 01608
Kamal Kant Sahu Department of Internal Medicine Saint Vincent Hospital Worcester, Massachusetts USA, 01608
Sudesh Kaul Department of Internal Medicine Saint Vincent Hospital Worcester, Massachusetts USA, 01608
Amos Lal Saint Vincent Hospital, Worcester, MA

DOI: https://doi.org/10.23750/abm.v91i1.8914

Keywords:

Tyrosine kinase inhibitors; Dasatinib; Pleural; Pericardial effusion

Downloads

Published

19-03-2020

Issue

Vol. 91 No. 1 (2020)

Section

E-LETTERS: COMMENTS AND RESPONSES

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

Mishra AK, Sahu KK, Kaul S, Lal A. Dasatinib induced pleuro–pericardial effusion: To the Editor. Acta Biomed [Internet]. 2020 Mar. 19 [cited 2024 Jul. 18];91(1):142-3. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/8914

Download Citation